Tertensif en es it fr

Tertensif Brand names, Tertensif Analogs

Tertensif Brand Names Mixture

  • No information avaliable

Tertensif Chemical_Formula


Tertensif RX_link


Tertensif fda sheet

Tertensif FDA

Tertensif msds (material safety sheet)

Tertensif MSDS

Tertensif Synthesis Reference

No information avaliable

Tertensif Molecular Weight

365.835 g/mol

Tertensif Melting Point

161 oC

Tertensif H2O Solubility

75 mg/L

Tertensif State


Tertensif LogP


Tertensif Dosage Forms


Tertensif Indication

For the treatment of hypertension, alone or in combination with other antihypertensive drugs as well as for the treatment of salt and fluid retention associated with congestive heart failure or edema from pregnancy.

Tertensif Pharmacology

Indapamide is an antihypertensive and a diuretic. It contains both a polar sulfamoyl chlorobenzamide moiety and a lipid- soluble methylindoline moiety. Indapamide bears a structural similarity to the triazide diuretics which are known to decrease vascular smooth muscle reactivity. However, it differs chemically from the thiazides in that it does not possess the thiazide ring system and contains only one sulfonamide group. Indapamide appears to cause vasodilation, probably by inhibiting the passage of calcium and other ions (sodium, potassium) across membranes. This same effect may cause hypokalcemia in susceptible individuals. Indapamide has also been shown to cause uterine myometrial relaxation in experimental animals. Overall, indapamide has an extra-renal antihypertensive action resulting in a decrease in vascular hyperreactivity and a reduction in total peripheral and arteriolar resistance.

Tertensif Absorption

Rapidly absorbed from gastrointestinal tract.

Tertensif side effects and Toxicity

Side effects include electrolyte imbalance (potassium or salt depletion due to too much fluid loss), nausea, stomach disorders, vomiting, weakness

Tertensif Patient Information

No information avaliable

Tertensif Organisms Affected

Humans and other mammals